525 related articles for article (PubMed ID: 25020248)
41. Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study.
Lammi C; Zanoni C; Arnoldi A; Vistoli G
J Agric Food Chem; 2016 Dec; 64(51):9601-9606. PubMed ID: 27983830
[TBL] [Abstract][Full Text] [Related]
42. Peptide identification from a Porphyra dioica protein hydrolysate with antioxidant, angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory activities.
Cermeño M; Stack J; Tobin PR; O'Keeffe MB; Harnedy PA; Stengel DB; FitzGerald RJ
Food Funct; 2019 Jun; 10(6):3421-3429. PubMed ID: 31134998
[TBL] [Abstract][Full Text] [Related]
43. Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties.
Nongonierma AB; Maux SL; Esteveny C; FitzGerald RJ
J Sci Food Agric; 2017 Mar; 97(4):1093-1101. PubMed ID: 27271791
[TBL] [Abstract][Full Text] [Related]
44. Meat Proteins as Dipeptidyl Peptidase IV Inhibitors and Glucose Uptake Stimulating Peptides for the Management of a Type 2 Diabetes Mellitus In Silico Study.
Kęska P; Stadnik J; Bąk O; Borowski P
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640215
[TBL] [Abstract][Full Text] [Related]
45. A study to evaluate the potential of an in silico approach for predicting dipeptidyl peptidase-IV inhibitory activity in vitro of protein hydrolysates.
Wang TY; Hsieh CH; Hung CC; Jao CL; Lin PY; Hsieh YL; Hsu KC
Food Chem; 2017 Nov; 234():431-438. PubMed ID: 28551257
[TBL] [Abstract][Full Text] [Related]
46. Investigation of
Li Y; Aiello G; Fassi EMA; Boschin G; Bartolomei M; Bollati C; Roda G; Arnoldi A; Grazioso G; Lammi C
Nutrients; 2021 May; 13(5):. PubMed ID: 34066103
[No Abstract] [Full Text] [Related]
47. Dipeptidyl Peptidase-IV Inhibitory Activity and Related Molecular Mechanism of Bovine α-Lactalbumin-Derived Peptides.
Gao J; Gong H; Mao X
Molecules; 2020 Jun; 25(13):. PubMed ID: 32630113
[TBL] [Abstract][Full Text] [Related]
48. Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum.
Lammi C; Bollati C; Ferruzza S; Ranaldi G; Sambuy Y; Arnoldi A
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30104520
[TBL] [Abstract][Full Text] [Related]
49. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.
Nongonierma AB; FitzGerald RJ
Peptides; 2016 May; 79():1-7. PubMed ID: 26988873
[TBL] [Abstract][Full Text] [Related]
50. Peptides with Potential Cardioprotective Effects Derived from Dry-Cured Ham Byproducts.
Gallego M; Mora L; Hayes M; Reig M; Toldrá F
J Agric Food Chem; 2019 Jan; 67(4):1115-1126. PubMed ID: 30648392
[TBL] [Abstract][Full Text] [Related]
51. Comparative peptidomic profile and bioactivities of cooked beef, pork, chicken and turkey meat after in vitro gastro-intestinal digestion.
Martini S; Conte A; Tagliazucchi D
J Proteomics; 2019 Sep; 208():103500. PubMed ID: 31454557
[TBL] [Abstract][Full Text] [Related]
52. Isolation and characterization of peptides with dipeptidyl peptidase-IV inhibitory activity from pepsin-treated bovine whey proteins.
Lacroix IM; Li-Chan EC
Peptides; 2014 Apr; 54():39-48. PubMed ID: 24440459
[TBL] [Abstract][Full Text] [Related]
53. Investigation into the bioavailability of milk protein-derived peptides with dipeptidyl-peptidase IV inhibitory activity using Caco-2 cell monolayers.
Lacroix IME; Chen XM; Kitts DD; Li-Chan ECY
Food Funct; 2017 Feb; 8(2):701-709. PubMed ID: 28098291
[TBL] [Abstract][Full Text] [Related]
54. Identification of DPP-IV inhibitory peptides derived from buffalo colostrum: Mining through bioinformatics, in silico and in vitro approaches.
Ashok A; H S A
J Mol Recognit; 2024 Jul; 37(4):e3090. PubMed ID: 38803118
[TBL] [Abstract][Full Text] [Related]
55. Identification, characterization, and insights into the mechanism of novel dipeptidyl peptidase-IV inhibitory peptides from yak hemoglobin by in silico exploration, molecular docking, and in vitro assessment.
Zhang J; Wu Y; Tang H; Li H; Da S; Ciren D; Peng X; Zhao K
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129191. PubMed ID: 38184042
[TBL] [Abstract][Full Text] [Related]
56. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
57. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes.
Power O; Nongonierma AB; Jakeman P; FitzGerald RJ
Proc Nutr Soc; 2014 Feb; 73(1):34-46. PubMed ID: 24131508
[TBL] [Abstract][Full Text] [Related]
58. In silico identification of antidiabetic and hypotensive potential bioactive peptides from the sheep milk proteins-a molecular docking study.
Iram D; Sansi MS; Zanab S; Vij S; Ashutosh ; Meena S
J Food Biochem; 2022 Mar; ():e14137. PubMed ID: 35352361
[TBL] [Abstract][Full Text] [Related]
59. Discovery, synthesis, and in vitro evaluation of a novel bioactive peptide for ACE and DPP-IV inhibitory activity.
Ashok A; Brijesha N; Aparna HS
Eur J Med Chem; 2019 Oct; 180():99-110. PubMed ID: 31301567
[TBL] [Abstract][Full Text] [Related]
60. In Vitro Metabolic Stability of a Casein-Derived Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptide VPYPQ and Its Controlled Release from Casein by Enzymatic Hydrolysis.
Zheng L; Xu Q; Lin L; Zeng XA; Sun B; Zhao M
J Agric Food Chem; 2019 Sep; 67(38):10604-10613. PubMed ID: 31466448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
